Cargando…

A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites

(1). An essential component of any treatment for patients with irritable bowel syndrome (IBS) is an adequate diet. Currently, a low FODMAP diet is recommended as a first-line therapy, but it does not relieve abdominal discomfort in all patients, and alternative nutritional treatment is required. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Chojnacki, Cezary, Medrek-Socha, Marta, Blonska, Aleksandra, Zajdel, Radoslaw, Chojnacki, Jan, Poplawski, Tomasz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738361/
https://www.ncbi.nlm.nih.gov/pubmed/36499643
http://dx.doi.org/10.3390/ijms232315314
_version_ 1784847522195308544
author Chojnacki, Cezary
Medrek-Socha, Marta
Blonska, Aleksandra
Zajdel, Radoslaw
Chojnacki, Jan
Poplawski, Tomasz
author_facet Chojnacki, Cezary
Medrek-Socha, Marta
Blonska, Aleksandra
Zajdel, Radoslaw
Chojnacki, Jan
Poplawski, Tomasz
author_sort Chojnacki, Cezary
collection PubMed
description (1). An essential component of any treatment for patients with irritable bowel syndrome (IBS) is an adequate diet. Currently, a low FODMAP diet is recommended as a first-line therapy, but it does not relieve abdominal discomfort in all patients, and alternative nutritional treatment is required. The purpose of this study was to evaluate the effect of a tryptophan-lowering diet (TRP) on abdominal and mental symptoms in patients with irritable bowel syndrome with predominant diarrhea (IBS-D). (2). The study included 40 patients with IBS-D, and 40 healthy subjects served as a baseline for IBS-D patients, after excluding comorbidities. The TRP intake was calculated using the nutritional calculator. The severity of abdominal symptoms was assessed using the gastrointestinal symptom rating scale (GSRS-IBS). Mental state was assessed using the Hamilton anxiety rating scale (HAM-A), the Hamilton depression rating scale (HAM-D), and the insomnia severity index (ISI). The serum levels of serotonin and melatonin and the urinary excretion of their metabolites 5-hydroxyindoleacetic acid (5-HIAA) and 6-sulfatoxymelatonin (aMT6) were determined by the ELISA method. The severity of symptoms and laboratory data were analyzed before and after a 12 week diet with tryptophan restricted to a daily dose 10 mg per kilogram body weight. (3). Compared to the control group, patients with IBS-D had a higher serum level of serotonin (198.2 ± 38.1 vs. 142.3 ± 36.4 ng/mL; p < 0.001) but a similar level of melatonin (8.6 ± 1.1 vs. 9.4 ± 3.0 pg/mL; p > 0.05). The urinary excretion of 5-HIAA was also higher in patients with IBS-D patients (7.7 ± 1.5 vs. 6.0 ± 1.7 mg/24 h; p < 0.001). After nutritional treatment, both the serum serotonin level and the urinary 5-HIAA excretion significantly decreased (p < 0.001). The severity of the abdominal symptoms and anxiety also decreased, while the HAM-D score and the ISI score remained unchanged (4). Lowering the dietary intake of tryptophan may reduce abdominal complaints and does not alter the mental state of IBS-D patients.
format Online
Article
Text
id pubmed-9738361
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97383612022-12-11 A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites Chojnacki, Cezary Medrek-Socha, Marta Blonska, Aleksandra Zajdel, Radoslaw Chojnacki, Jan Poplawski, Tomasz Int J Mol Sci Article (1). An essential component of any treatment for patients with irritable bowel syndrome (IBS) is an adequate diet. Currently, a low FODMAP diet is recommended as a first-line therapy, but it does not relieve abdominal discomfort in all patients, and alternative nutritional treatment is required. The purpose of this study was to evaluate the effect of a tryptophan-lowering diet (TRP) on abdominal and mental symptoms in patients with irritable bowel syndrome with predominant diarrhea (IBS-D). (2). The study included 40 patients with IBS-D, and 40 healthy subjects served as a baseline for IBS-D patients, after excluding comorbidities. The TRP intake was calculated using the nutritional calculator. The severity of abdominal symptoms was assessed using the gastrointestinal symptom rating scale (GSRS-IBS). Mental state was assessed using the Hamilton anxiety rating scale (HAM-A), the Hamilton depression rating scale (HAM-D), and the insomnia severity index (ISI). The serum levels of serotonin and melatonin and the urinary excretion of their metabolites 5-hydroxyindoleacetic acid (5-HIAA) and 6-sulfatoxymelatonin (aMT6) were determined by the ELISA method. The severity of symptoms and laboratory data were analyzed before and after a 12 week diet with tryptophan restricted to a daily dose 10 mg per kilogram body weight. (3). Compared to the control group, patients with IBS-D had a higher serum level of serotonin (198.2 ± 38.1 vs. 142.3 ± 36.4 ng/mL; p < 0.001) but a similar level of melatonin (8.6 ± 1.1 vs. 9.4 ± 3.0 pg/mL; p > 0.05). The urinary excretion of 5-HIAA was also higher in patients with IBS-D patients (7.7 ± 1.5 vs. 6.0 ± 1.7 mg/24 h; p < 0.001). After nutritional treatment, both the serum serotonin level and the urinary 5-HIAA excretion significantly decreased (p < 0.001). The severity of the abdominal symptoms and anxiety also decreased, while the HAM-D score and the ISI score remained unchanged (4). Lowering the dietary intake of tryptophan may reduce abdominal complaints and does not alter the mental state of IBS-D patients. MDPI 2022-12-05 /pmc/articles/PMC9738361/ /pubmed/36499643 http://dx.doi.org/10.3390/ijms232315314 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chojnacki, Cezary
Medrek-Socha, Marta
Blonska, Aleksandra
Zajdel, Radoslaw
Chojnacki, Jan
Poplawski, Tomasz
A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites
title A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites
title_full A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites
title_fullStr A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites
title_full_unstemmed A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites
title_short A Reduced Tryptophan Diet in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Improves Their Abdominal Symptoms and Their Quality of Life through Reduction of Serotonin Levels and Its Urinary Metabolites
title_sort reduced tryptophan diet in patients with diarrhoea-predominant irritable bowel syndrome improves their abdominal symptoms and their quality of life through reduction of serotonin levels and its urinary metabolites
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738361/
https://www.ncbi.nlm.nih.gov/pubmed/36499643
http://dx.doi.org/10.3390/ijms232315314
work_keys_str_mv AT chojnackicezary areducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites
AT medreksochamarta areducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites
AT blonskaaleksandra areducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites
AT zajdelradoslaw areducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites
AT chojnackijan areducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites
AT poplawskitomasz areducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites
AT chojnackicezary reducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites
AT medreksochamarta reducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites
AT blonskaaleksandra reducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites
AT zajdelradoslaw reducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites
AT chojnackijan reducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites
AT poplawskitomasz reducedtryptophandietinpatientswithdiarrhoeapredominantirritablebowelsyndromeimprovestheirabdominalsymptomsandtheirqualityoflifethroughreductionofserotoninlevelsanditsurinarymetabolites